Literature DB >> 2376022

Leukotriene C4 decreases the activity of respiratory cilia in vitro.

Z Weisman1, A Fink, A Alon, Z Poliak, E Tabachnik, L Priscu, Z Bentwich.   

Abstract

In the present study we assessed the effect of leukotriene C4 on ciliary beat frequency in vitro. Chicken tracheas were sliced into thin rings and ciliary activity was viewed microscopically. Ciliary beat frequency was measured through an optical fibre by a fast Fourier transformer analyser and recorded on an oscilloscope. Ciliary beat frequency was measured at one fixed point during 30 min at room temperature in RPMI-HEPES medium alone and in medium containing leukotriene C4 at a range of concentrations (10(-6)-10(-9) M). Our results demonstrate that leukotriene C4 (10(-7) and 10(-8) M) caused a significant decrease in ciliary beat frequency in all tracheal rings tested (mean decrease of 24%). The specificity and Ca2(+)-dependency of leukotriene C4 activity was elucidated by the ability of FPL 55712 (SRS-A specific antagonist), Ca2(+)-free medium, calcium channel blockers (nifedipine and verapamil) and the calmodulin inhibitor trifluroperazine to abrogate its effect on ciliary beating.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2376022     DOI: 10.1111/j.1365-2222.1990.tb02799.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  3 in total

1.  Polymorphonuclear leukocyte-generated oxygen metabolites decrease beat frequency of human respiratory cilia.

Authors:  A Kantar; N Oggiano; P L Giorgi; P C Braga; R Fiorini
Journal:  Lung       Date:  1994       Impact factor: 2.584

2.  Involvement of protein kinase C in 5-HT-stimulated ciliary activity in Helisoma trivolvis embryos.

Authors:  K J Christopher; K G Young; J P Chang; J I Goldberg
Journal:  J Physiol       Date:  1999-03-01       Impact factor: 5.182

3.  Histamine and leukotriene C4 effects on in vitro ciliary beat frequency of human upper respiratory cilia.

Authors:  P J Schuil; J M van Gelder; M ten Berge; K Graamans; E H Huizing
Journal:  Eur Arch Otorhinolaryngol       Date:  1994       Impact factor: 2.503

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.